Samuel Malkin

15PUBLICATIONS
21CO-AUTHORS
Evolutionary computationPharmacogenomicsCardiovascular medicine and haematology not elsewhere classifiedExercise physiologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 31, 2026
Projecting the Long-Term Cost-Effectiveness of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogs in Italy Using the Prime T2D Model.

|Dec 20, 2025
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW.

Peter Rossing, Morten Lindhardt, Christian Klyver Tikkanen

|Jul 17, 2025
Cost-Effectiveness of Drug-Coated Balloons in the Treatment of Coronary Small Vessel Disease: A Report From the BASKET-SMALL 2 Randomized Controlled Trial.

Marco E G V Cattaneo, Michael Coslovsky, Samuel J P Malkin

|Feb 19, 2025
The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.

Mohamed Elnaggar, Joana Nunes Mansinho, Samuel J P Malkin

|Sep 29, 2023
Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy.

Hongye Ren, Sasha Berry, Samuel Joseph Paul Malkin

|Aug 01, 2023
Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide.

Sasha Berry, Barrie Chubb, Annabel Acs

Pageof 3

Frequent Collaborators

7 joint publications

Barnaby Hunt

3 joint publications

Barrie Chubb

2 joint publications

Marc Evans

2 joint publications

Stephen C Bain